Growth through Acquisition Devicare’s recent plans to acquire IP-6 International indicate a strategic expansion into the North American market, presenting a sales opportunity to offer complementary products or services that support their growth and integration efforts.

Funding and Investment With recent investments totaling over 3 million USD, including government-backed loans, Devicare is positioned for product development and market entry, signaling strong potential for partnering on innovative urology solutions and digital health tools.

Market Entry Strategy Partnering with Diem Labs to introduce digital therapeutics in the US highlights their openness to innovative medical technologies, creating opportunities to sell digital health solutions, diagnostic devices, or support services aligned with their strategic focus.

Product Development Focus Devicare is investing heavily in developing apps and digital therapies for urological health, which opens avenues for sales of related digital platforms, mobile health applications, or integration services into their existing treatment solutions.

European Foundations Based in Catalonia with active partnerships and funding from regional biotech initiatives, Devicare’s strong European presence offers a gateway for sales of healthcare technologies, diagnostic equipment, and research collaborations within the biotech and medical device sectors.